CGTX · Company research
Cognition Therapeutics, Inc. Common Stock (CGTX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A drug patent runs to 2045. FDA approval may allow up to five more years. - Stock Titan | A drug patent runs to 2045. FDA approval may allow up to five more years. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| An experimental drug slowed the progression of hallucinations and delusions by 89% vs. placebo. - Stock Titan | An experimental drug slowed the progression of hallucinations and delusions by 89% vs. placebo. Stock Titan | View source ↗ | Stock Titan | Sep 29, 2026 | neutral | 0 | 0.6 |
| Cognition Therapeutics Stock (CGTX) Opinions on biotech upside speculation | CGTX Stock News - Quiver Quantitative | Cognition Therapeutics Stock (CGTX) Opinions on biotech upside speculation | CGTX Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 8, 2026 | neutral | 0 | 0.6 |
| Cognition plans mid-2027 dementia trial; patent could extend to 2045 - Stock Titan | Cognition plans mid-2027 dementia trial; patent could extend to 2045 Stock Titan | View source ↗ | Stock Titan | Aug 6, 2026 | neutral | 0 | 0.6 |
| Is Cognition Therapeutics (NASDAQ:CGTX) In A Good Position To Invest In Growth? - Simply Wall Street | Is Cognition Therapeutics (NASDAQ:CGTX) In A Good Position To Invest In Growth? Simply Wall Street | View source ↗ | Simply Wall Street | Jul 16, 2026 | neutral | 0 | 0.6 |
| $CGTX stock is down 9% today. Here's what we see in our data. - Quiver Quantitative | $CGTX stock is down 9% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 6, 2026 | neutral | 0 | 0.6 |
| We're Keeping An Eye On Cognition Therapeutics' (NASDAQ:CGTX) Cash Burn Rate - Moomoo | We're Keeping An Eye On Cognition Therapeutics' (NASDAQ:CGTX) Cash Burn Rate Moomoo | View source ↗ | Moomoo | Jun 29, 2026 | neutral | 0 | 0.6 |
| CGTX Forecast — Price Target — Prediction for 2027 - TradingView | CGTX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Market Movers | Winners: SKYQ, NVCT, ABSI | Losers: ATLN, HTZ, CGTX - Trefis | Market Movers | Winners: SKYQ, NVCT, ABSI | Losers: ATLN, HTZ, CGTX Trefis | View source ↗ | Trefis | Jun 25, 2026 | neutral | 0 | 0.6 |
| Cognition Therapeutics Gets Positive FDA Feedback Over Phase 3 Study Of DLB Psychosis – But CGTX Stock Just Crashed 33% - Stocktwits | Cognition Therapeutics Gets Positive FDA Feedback Over Phase 3 Study Of DLB Psychosis – But CGTX Stock Just Crashed 33% Stocktwits | View source ↗ | Stocktwits | Jun 24, 2026 | neutral | 0 | 0.6 |
| Cognition Therapeutics stock rises on FDA trial alignment - Investing.com | Cognition Therapeutics stock rises on FDA trial alignment Investing.com | View source ↗ | Investing.com | Jun 24, 2026 | neutral | 0 | 0.6 |
| There are notable gap-ups and gap-downs in today's session. - ChartMill | There are notable gap-ups and gap-downs in today's session. ChartMill | View source ↗ | ChartMill | Jun 24, 2026 | neutral | 0 | 0.6 |
| Cognition Therapeutics Advances After FDA Supports Key Elements of Pivotal Trial Plan (CGTX) - Yahoo Finance | Cognition Therapeutics Advances After FDA Supports Key Elements of Pivotal Trial Plan (CGTX) Yahoo Finance | View source ↗ | Yahoo Finance | Jun 24, 2026 | neutral | 0 | 0.6 |
| Is Cognition Therapeutics, Inc. (CGTX) Moving Closer to a Registrational Trial in Dementia With Lewy Bodies? - Yahoo Finance | Is Cognition Therapeutics, Inc. (CGTX) Moving Closer to a Registrational Trial in Dementia With Lewy Bodies? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 2, 2026 | neutral | 0 | 0.6 |
| Neuro drug developer to outline DLB psychosis plans at June events - Stock Titan | Neuro drug developer to outline DLB psychosis plans at June events Stock Titan | View source ↗ | Stock Titan | Jun 1, 2026 | neutral | 0 | 0.6 |
| $CGTX stock is up 14% today. Here's what we see in our data. - Quiver Quantitative | $CGTX stock is up 14% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | May 20, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.